Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

41
Actual shortage: 3 (7%)
Anticipated shortage: 1 (2%)
Avoided shortage: 0 (0%)
Resolved: 37 (90%)

Discontinuation Reports

2
To be discontinued: 0 (0%)
Discontinued: 2 (100%)
Reversed: 0 (0%)

Late reports

6 (14%)

Overdue reports

1 (25%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CONSTELLA 290MCG CAPSULE Resolved 2018-11-20 2019-01-09 67153
CONSTELLA 290MCG CAPSULE Resolved 2019-02-19 2019-02-27 76263
CONSTELLA 290MCG CAPSULE Resolved 2019-05-25 2019-06-07 84770
CONSTELLA 72MCG CAPSULE Resolved 2019-05-25 2019-06-07 84773
FETZIMA 20MG CAPSULE (EXTENDED RELEASE) Resolved 2019-05-25 2019-06-07 84776
FETZIMA 80MG CAPSULE (EXTENDED RELEASE) Resolved 2019-05-25 2019-06-07 84779
LUMIGAN 0.03% SOLUTION Actual shortage 2017-04-05 2017-10-05 5736
MACROBID 100MG CAPSULE Resolved 2017-06-29 2017-10-04 14319
OXYTROL 36MG PATCH Resolved 2018-09-25 2018-11-03 62335
OZURDEX 0.7MG IMPLANT Resolved 2019-02-21 2019-03-21 76570
OZURDEX 0.7MG IMPLANT Resolved 2019-04-08 2019-04-27 80819
RAPAFLO 4MG CAPSULE Resolved 2018-07-20 2018-09-25 56121
RESTASIS MULTIDOSE 0.05% EMULSION Actual shortage 2019-02-01 2019-02-01 74356
TAZORAC 0.05% GEL Resolved 2018-11-01 2019-05-18 65978
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
VIIBRYD 10MG TABLET Resolved 2019-01-15 2019-02-28 72344
VIIBRYD 10MG TABLET Resolved 2019-02-28 2019-05-14 77159
VIIBRYD 20MG TABLET Resolved 2019-01-15 2019-05-09 72342
VIIBRYD 20MG TABLET Resolved 2019-05-25 2019-06-07 84782

Showing 21 to 40 of 41

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALOCRIL 2% LIQUID Discontinued 2018-11-28 2019-04-02 67803
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Discontinued 2017-08-04 2017-08-04 18275